Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Predict branded drug patent expiration
  • Identify first generic entrants

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Hydroxyzine pamoate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for hydroxyzine pamoate?

Hydroxyzine pamoate is the generic ingredient in three branded drugs marketed by Watson Labs, Heritage Pharma, Teva, Sandoz, Superpharm, Par Pharm, Impax Labs Inc, Pfizer, Ivax Sub Teva Pharms, Barr, Vangard, and Duramed Pharms Barr, and is included in thirty-seven NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for hydroxyzine pamoate. Thirty-six suppliers are listed for this compound.

Summary for Generic Name: hydroxyzine pamoate

Drug Master File Entries: see list19
Suppliers / Packagers: see list36
Bulk Api Vendors: see list26
Clinical Trials: see list9
Patent Applications: see list1,279
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:hydroxyzine pamoate at DailyMed

Pharmacology for Ingredient: hydroxyzine pamoate

Drug ClassAntihistamine
Mechanism of ActionHistamine Receptor Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms
hydroxyzine pamoate
CAPSULE;ORAL087761-001Mar 5, 1982DISCNNoNo► Subscribe► Subscribe
Par Pharm
hydroxyzine pamoate
CAPSULE;ORAL089145-001Mar 17, 1986DISCNNoNo► Subscribe► Subscribe
hydroxyzine pamoate
SUSPENSION;ORAL011795-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Watson Labs
hydroxyzine pamoate
CAPSULE;ORAL086840-001Jul 1, 1982DISCNNoNo► Subscribe► Subscribe
hydroxyzine pamoate
CAPSULE;ORAL088393-001Sep 19, 1983DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.